These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2848089)

  • 1. Characterization of circulating pro-opiomelanocortin-related peptides in human septic shock.
    McLoughlin L; Evans SF; Watson JD; Hinds CJ; Rees LH
    J Endocrinol; 1988 Oct; 119(1):159-65. PubMed ID: 2848089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a.
    Morano MI; Estivariz FE
    J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
    Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
    Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-amidated peptides derived from pro-opiomelanocortin in normal human pituitary.
    Fenger M; Johnsen AH
    Biochem J; 1988 Mar; 250(3):781-8. PubMed ID: 2839146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of pro-opiomelanocortin-derived peptides in the human brain.
    Emson PC; Corder R; Ratter SJ; Tomlin S; Lowry PJ; Ress LH; Arregui A; Rosser MN
    Neuroendocrinology; 1984 Jan; 38(1):45-50. PubMed ID: 6320029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 60 YEARS OF POMC: Purification and biological characterisation of melanotrophins and corticotrophins.
    Lowry P
    J Mol Endocrinol; 2016 May; 56(4):T1-T12. PubMed ID: 26643914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of pro gamma MSH, gamma MSH, ACTH and beta endorphin/beta lipotrophin in the fetal sheep pituitary: an ontogenetic study.
    Mulvogue HM; McMillen IC; Robinson PM; Perry RA
    J Dev Physiol; 1986 Oct; 8(5):355-68. PubMed ID: 3025283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and possible function of pro-opiomelanocortin-derived peptides in the testis.
    Bardin CW; Shaha C; Mather J; Salomon Y; Margioris AN; Liotta AS; Gerendai I; Chen CL; Krieger DT
    Ann N Y Acad Sci; 1984; 438():346-64. PubMed ID: 6100019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen regulates pro-opiomelanocortin processing.
    Wang N; Zhang L; Miles L; Hoover-Plow J
    J Thromb Haemost; 2004 May; 2(5):785-96. PubMed ID: 15099286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of immunoreactive proopiomelanocortin peptides and cortisol in clinically normal cats.
    Peterson ME; Kemppainen RJ; Orth DN
    Am J Vet Res; 1994 Feb; 55(2):295-300. PubMed ID: 8172423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues.
    DeBold CR; Nicholson WE; Orth DN
    Endocrinology; 1988 Jun; 122(6):2648-57. PubMed ID: 2836169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute unilateral nephrectomy elicits a specific increase in plasma of peptides derived from the N-terminal region of proopiomelanocortin.
    Qiu C; Valentin JP; Chen XW; Wiedemann E; Humphreys MH
    J Am Soc Nephrol; 1992 Nov; 3(5):1105-12. PubMed ID: 1336405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic naevi.
    Nagahama M; Funasaka Y; Fernandez-Frez ML; Ohashi A; Chakraborty AK; Ueda M; Ichihashi M
    Br J Dermatol; 1998 Jun; 138(6):981-5. PubMed ID: 9747358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from pro-opiocortin in the pituitary gland of the dogfish, Squalus acanthias.
    Denning-Kendall PA; Sumpter JP; Lowry PJ
    J Endocrinol; 1982 Jun; 93(3):381-90. PubMed ID: 6283008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of N-terminal pro-opiomelanocortin-derived peptides in response to acute haemorrhagic stress in conscious sheep.
    Owens P; Lovelock M; Chan EC; Falconer J; Ling N; Smith R
    Biochem Biophys Res Commun; 1985 Dec; 133(2):648-53. PubMed ID: 2935148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock.
    Matejec R; Kayser F; Schmal F; Uhle F; Bödeker RH; Maxeiner H; Kolbe JA
    Peptides; 2013 Sep; 47():133-41. PubMed ID: 23891702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POMC-derived peptides and their biological action.
    Solomon S
    Ann N Y Acad Sci; 1999 Oct; 885():22-40. PubMed ID: 10816639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.